JPRN-jRCT2080220093
Unknown
Phase 2
ate phase II clinical study of intra-arterial chemotherapy using SM-11355 in patients with hepatocellular carcinoma (HCC) .
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dainippon Sumitomo Pharma Co., Ltd.
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\-HCC confirmed histologically and/or clinically diagnosed by angiography and CT
- •\-Hypervascular HCC
- •\-Not indicated for hepatectomy, PEI, PMCT and RFA
- •\-Stage II or III (Liver Cancer Study Group of Japan: Classification of primary liver cancer)
- •\-ECOG performance status (PS) of 0, 1 or 2
- •\-Aged 20 to less than 75
- •\-Patients with a history of severe allergy to iodine\-containing drugs and/or contrast media
- •\-Severe complication (especially severe thyroid or heart disease)
- •\-Active malignancies of other organs
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A clinical trial of intra-arterial infusion chemotherapy with cisplatin for head and neck cancerHead and neck squamous cell carcinomaJPRN-UMIN000017656Department of Radiology Mie University Graduate School of Medicine18
Recruiting
Not Applicable
The clinical study of intra-arterial chemotherapy using several anticancer agents for oral cancerOral cancerJPRN-UMIN000037859Fukushima Medical University Hospital50
Active, not recruiting
Not Applicable
Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) - TACE and sorafenib for HCChistologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCCMedDRA version: 9.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableEUCTR2007-000730-40-DEHeinrich-Heine-Universität Düsseldorf
Completed
Phase 2
Randomised phase II study of Intra-arterial infusion therapy with cisplatin suspension in lipiodol and 5-fluorouracil(New FP therapy)versus sorafenib in advanced hepatocellular carcinoma.advanced hepatocellular carcinomaJPRN-UMIN000024661ational Hospital Organization Kyushu Cancer Center Department of Hepato-biliary-pancreatology120
Completed
Phase 1
Phase I/II study of transcatheter arterial chemo-embolization with DDP-H and degradable starch microspheres for hepatic metastases of colorectal cancerColorectal CancerJPRN-UMIN000001168Radiology, Nara Medical University Hospital27